The board of directors of AbbVie Inc. declared the company's first quarterly cash dividend of $0.40 per share. The cash dividend is payable Feb. 15, 2013 to stockholders of record at the close of business on Jan.
15, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
171.4 USD | +0.99% | +3.17% | +10.58% |
06-19 | AbbVie: FDA approval in ulcerative colitis | CF |
06-18 | AbbVie's Skyrizi Gets FDA Approval to Treat Certain Instances of Ulcerative Colitis | DJ |
The board of directors of AbbVie Inc. declared the company's first quarterly cash dividend of $0.40 per share. The cash dividend is payable Feb. 15, 2013 to stockholders of record at the close of business on Jan.
15, 2013.
1st Jan change | Capi. | |
---|---|---|
+10.58% | 303B | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B | |
-4.79% | 155B |